Top Markets
Coin of the day
Bionoid Pharma, Inc. Bionoid Pharma, Inc.

Bionoid Pharma, Inc.

BINP
Rank in Stocks #37552
Bionoid Pharma, Inc. functions as a medical technology enterprise. This company... Bionoid Pharma, Inc. functions as a medical technology enterprise. This company concentrates on the creation and commercialization of advanced medical instruments and solutions, primarily targeting the orthopedic and pain management industries. Founded on October 20, 1997, its corporate headquarters are situated in Beverly Hills, California.
Share Price
$0.03
Last synced: 2026-01-02
Market Cap
$1.62M
Change (1 day)
0.00%
Change (1 year)
11.94%
Country
US
Trade Bionoid Pharma, Inc. (BINP)

Category

P/E ratio for Bionoid Pharma, Inc. (BINP)
P/E ratio as of 2026 TTM: 0
According to Bionoid Pharma, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Bionoid Pharma, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.